UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000014397
Receipt No. R000016752
Official scientific title of the study Chemoradiation followed by maintenance therapy for patients with locally advanced cutaneous angiosarcoma
Date of disclosure of the study information 2014/07/10
Last modified on 2016/06/29 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Chemoradiation followed by maintenance therapy for patients with locally advanced cutaneous angiosarcoma
Title of the study (Brief title) chemoradiation and maintenance therapy for angiosarcoma
Region
Japan

Condition
Condition Cutaneous angiosarcoma
Classification by specialty
Dermatology
Classification by malignancy Malignancy
Genomic information YES

Objectives
Narrative objectives1 Investigate the efficacy and safety of chemoradiation using paclitaxel for patients with cutaneous angiosarcoma
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase Phase II

Assessment
Primary outcomes Overall survival rate
Key secondary outcomes response ratio, duration of response, time to progression, adverse effect, time to distant metastasis, overall survival time, tumor-specific survival time

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Chemoradiation+Maintenance therapy
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
85 years-old >=
Gender Male and Female
Key inclusion criteria Cutaneous angiosarcoma of the head and neck resion/PS 0 or 1
Key exclusion criteria PS 2 or 3/metastasis/prior therapy
Target sample size 60

Research contact person
Name of lead principal investigator Yasuhiro Fujisawa
Organization University of Tsukuba
Division name Dermatology
Address 1-1-1 Tennodai, Tsukuba
TEL 029-853-3128
Email fujisan@md.tsukuba.ac.jp

Public contact
Name of contact person Yasuhiro Fujisawa
Organization University of Tsukuba
Division name Dermatology
Address 1-1-1 Tennodai, Tsukuba
TEL 029-853-3128
Homepage URL
Email fujisan@md.tsukuba.ac.jp

Sponsor
Institute University of Tsukuba
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization University of Tsukuba
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 07 Month 10 Day

Progress
Recruitment status Preinitiation
Date of protocol fixation
2015 Year 01 Month 31 Day
Anticipated trial start date
2015 Year 03 Month 01 Day
Last follow-up date
2022 Year 03 Month 31 Day
Date of closure to data entry
2022 Year 03 Month 31 Day
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2014 Year 06 Month 27 Day
Last modified on
2016 Year 06 Month 29 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000016752